Evidence map›Paper›PMID 27848944›Full record

ArticleEuropean journal of human genetics : EJHG2017

Clinical exome sequencing: results from 2819 samples reflecting 1000 families.

Daniel Trujillano, Aida M Bertoli-Avella, Krishna Kumar Kandaswamy, Maximilian Er Weiss, Julia Köster, Anett Marais, Omid Paknia, Rolf Schröder, Jose Maria Garcia-Aznar, Martin Werber and 17 more

Open access · hybridAbstract readEvaluation Study
In one paragraph

Article in European journal of human genetics : EJHG, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 193 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
193citing papers in PubMed, 2 pooled it
35.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

193 citing papers in PubMed, 2 syntheses or guidelines pooled it, 366 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. medRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. BiallelicFrontiers in genetics · 2026
    Article
  13. Article
  14. Expanding the Genetic and Phenotypic Spectrum of DYT-VPS16: The Importance of Splice-Site Variants.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

133 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 5 institutions in 2 countries.

Daniel TrujillanoCentogene AG, Rostock, Germany.
Aida M Bertoli-AvellaCentogene AG, Rostock, Germany.
Krishna Kumar KandaswamyCentogene AG, Rostock, Germany.
Maximilian Er WeissCentogene AG, Rostock, Germany.
Julia KösterCentogene AG, Rostock, Germany.
Anett MaraisCentogene AG, Rostock, Germany.
Omid PakniaCentogene AG, Rostock, Germany.
Rolf SchröderCentogene AG, Rostock, Germany.
Jose Maria Garcia-AznarCentogene AG, Rostock, Germany.
Martin WerberCentogene AG, Rostock, Germany.
Oliver BrandauCentogene AG, Rostock, Germany.
Maria Calvo Del CastilloCentogene AG, Rostock, Germany.
Caterina BaldiCentogene AG, Rostock, Germany.
Karen WesselCentogene AG, Rostock, Germany.
Shivendra KishoreCentogene AG, Rostock, Germany.
Nahid NahavandiCentogene AG, Rostock, Germany.
Wafaa EyaidDivision of Genetics, Department of Pediatrics, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Muhammad Talal Al RifaiCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Ahmed Al-RumayyanCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Waleed Al-TwaijriCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Ali AlothaimCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Amal AlhashemDivision of Metabolic and Genetics, Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Nouriya Al-SannaaDivision of Pediatrics, Johns Hopkins Aramco hospital, Dhahran Health Center, Saudi Aramco, Dhahran, Saudi Arabia.
Mohammed Al-BalwiCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Majid AlfadhelDivision of Genetics, Department of Pediatrics, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Arndt RolfsCentogene AG, Rostock, Germany.
Rami Abou JamraCentogene AG, Rostock, Germany.ORCID 0000-0002-1542-1399
Centogene (Germany) · DEKing Saud bin Abdulaziz University for Health Sciences · SARiyadh Armed Forces Hospital · SASaudi Aramco Medical Services Organization · SAUniversity Hospital Leipzig · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report our results of 1000 diagnostic WES cases based on 2819 sequenced samples from 54 countries with a wide phenotypic spectrum. Clinical information given by the requesting physicians was translated to HPO terms. WES processes were performed according to standardized settings. We identified the underlying pathogenic or likely pathogenic variants in 307 families (30.7%). In further 253 families (25.3%) a variant of unknown significance, possibly explaining the clinical symptoms of the index patient was identified. WES enabled timely diagnosing of genetic diseases, validation of causality of specific genetic disorders of PTPN23, KCTD3, SCN3A, PPOX, FRMPD4, and SCN1B, and setting dual diagnoses by detecting two causative variants in distinct genes in the same patient. We observed a better diagnostic yield in consanguineous families, in severe and in syndromic phenotypes. Our results suggest that WES has a better yield in patients that present with several symptoms, rather than an isolated abnormality. We also validate the clinical benefit of WES as an effective diagnostic tool, particularly in nonspecific or heterogeneous phenotypes. We recommend WES as a first-line diagnostic in all cases without a clear differential diagnosis, to facilitate personal medical care.

Indexed as

ExomeAdolescentAdultChildChild, PreschoolFemaleFlavoproteinsGenetic TestingGenotyping TechniquesHumansInfantInfant, NewbornIntracellular Signaling Peptides and ProteinsMaleMiddle AgedMitochondrial ProteinsFlavoproteinsFRMPD4 protein, humanIntracellular Signaling Peptides and ProteinsKCTD3 protein, humanMitochondrial ProteinsNAV1.3 Voltage-Gated Sodium ChannelPotassium ChannelsPPOX protein, humanProtein Tyrosine Phosphatases, Non-ReceptorProtoporphyrinogen OxidasePTPN23 protein, humanSCN1B protein, humanSCN3A protein, humanSodium ChannelsVoltage-Gated Sodium Channel beta-1 Subunit

Identifiers

PMID27848944
PMCPMC5255946
OpenAlexW2556048034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.